Systemic pharmacological verification of Guizhi Fuling decoction in treating endometriosis-associated pain.

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE:

Guizhi Fuling decoction (GZFL decoction) is a famous formula in the Synopsis of the Golden Chamber, which has a long history in treating endometriosis. However, its exact mechanism remains unclear.

AIM OF STUDY:

This study aims to explore the mechanism of GZFL decoction in treating endometriosis, especially in alleviating endometriosis-associated pain.

MATERIALS AND METHODS:

A combination of system pharmacology and pharmacodynamics was used to explore the specific mechanism of GZFL decoction in the treatment of endometriosis-associated pain. First, the TCMSP database was used to search the components of the GZFL decoction; the parameter index was set as oral bioavailability (OB) ≥ 30% and drug-likeness (DL) ≥ 0.18, while the active ingredients of the drug were screened out. The disease targets of endometriosis were obtained from the TTD, OMIM, Genecards, and DisGeNET databases; the keyword was "endometriosis pain". Network construction and analysis were performed using Cytoscape 3.7.2 software; the David database was used to enrich and analyze the pathways for alleviating endometriosis pain after GZFL decoction treatment. In addition, the network results were verified using experimental animal and cell research.

RESULTS:

The results showed the following targets: 76 for the effective chemical components in the prescription, 1329 for disease pain, and 278 for the intersection of drugs and endometriosis pain. The enrichment results for these targets showed that the TNF-PI3K/Akt pathway exhibited research significance. In endometriosis rat models, the GZFL decoction reduced the volume of lesions and relieved pain symptoms. It also reduced the serum levels of IL-6, IL-1β, and TNF-α as well as their expression in the lesion tissues. The GZFL decoction also suppressed the activation of PI3K/Akt downstream signaling proteins.

CONCLUSIONS:

GZFL decoction could reduce the volume of lesions, suppress inflammation, and decrease the sensitivity to pain in endometriosis rat models through inhibiting PI3K/Akt pathway. This study provides a possible target for traditional Chinese medicine in treating endometriosis-associated pain.

• Authors: Yang Gao, Wenjing Ji, Man Lu, Zhiheng Wang, Xurui Jia, Dawei Wang, Peng Cao, Chunping Hu, Xiaoyan Sun, Zhigang Wang
• Journal: Journal of ethnopharmacology (J Ethnopharmacol) Vol. 297 Pg. 115540 (Oct 28 2022) ISSN: 1872-7573 [Electronic] Ireland
• PMID: 35870685 (Publication Type: Journal Article)
• Copyright: Copyright © 2022 Elsevier B.V. All rights reserved.

Chemical References

• Drugs, Chinese Herbal
• Proto-Oncogene Proteins c-akt

Topics

• Animals
• Drugs, Chinese Herbal (pharmacology, therapeutic use)
• Endometriosis (drug therapy)
• Female
• Humans
• Molecular Docking Simulation
• Pain (drug therapy)
• Phosphatidylinositol 3-Kinases
• Proto-Oncogene Proteins c-akt
• Rats
• Wolfiporia